At a glance
ClinicalIndex Comparison RecordN/ACompleted· 135 enrolled
Drug / intervention
belladonna 16.2 mg and opium 60 mg suppositorydrug
Likely dose
belladonna 16.2 mg and opium 60 mg suppositoryfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy
In Brief
A clinical study evaluating belladonna 16.2 mg and opium 60 mg suppository for Pain. Completed, enrolled 135 participants across 1 site.
Detailed Summary
This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study. 50% of patients will receive the suppository, 50% of patients will not. Neither you or your surgeon will know which group you are in.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsVirginia Mason Hospital/Medical Center
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2008
First PostedMar 2009
Primary CompletionJul 2009
TodayJul 2026
First PostedMar 18, 2009
Enrollment StartOct 1, 2008
Primary CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 17.3 years ago
Interventions
belladonna 16.2 mg and opium 60 mg suppositorydrug
belladonna 16.2 mg and opium 60 mg suppository